TCM
BIIB icon

TimesSquare Capital Management’s Biogen BIIB Stock Holding History

TimesSquare Capital Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-26,792
Closed -$9.1M – 249
2014
Q4 		$9.1M Buy
26,792
+6,548
+32% +$2.12M 0.05% 229
2014
Q3 		$6.7M Buy
20,244
+9,491
+88% +$3.13M 0.04% 240
2014
Q2 		$3.39M Buy
10,753
+10,613
+7,581% +$3.19M 0.02% 237
2014
Q1 		$43K Buy
+140
New +$44.4K ﹤0.01% 242

Other funds holding BIIB

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

TimesSquare Capital Management's BIIB Position: Q1 2015 in Review

TimesSquare Capital Management sold out of Biogen (BIIB) in Q1 2015, closing a stake of 26,792 shares — an estimated $9.1M sold.

TimesSquare Capital Management first reported a position in BIIB in Q1 2014 and held it in 4 quarters. The position peaked at $9.1M in Q4 2014. 966 funds tracked by Wall St. Rank hold BIIB as of Q1 2015.

  • TimesSquare Capital Management reported no remaining Biogen position as of Q1 2015 after selling out during the quarter.
  • TimesSquare Capital Management sold 26,792 Biogen shares in Q1 2015, an estimated $9.1M.
  • TimesSquare Capital Management first reported a position in Biogen in Q1 2014 and held it in 4 quarters.
  • TimesSquare Capital Management's Biogen position peaked at $9.1M in Q4 2014.
  • 966 funds tracked by Wall St. Rank held Biogen as of Q1 2015.

Based on TimesSquare Capital Management's 13F filing for Q1 2015, filed 12 May 2015.